INFINITY BIO, INC.

Profile

Company Names

INFINITY BIO, INC.

Addresses

6200 SEAFORTH ST., BALTIMORE, MD 21224

2901 BOSTON STREET, #410, BALTIMORE, MD 21224

Phone Numbers

941-586-9188

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

2023

State Incorporated:

UNITED STATES

Total Amount Raised:

$11,516,093.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-06-13 
$5,000,000.00 
$7,000,000.00 
$2,000,000.00 
Equity 
2
2025-02-18 
$2,000,000.00 
$5,000,000.00 
$3,000,000.00 
Debt 
1
2023-06-16 
$4,516,093.00 
$4,516,093.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BILL 
 
CAMPBELL 
DIRECTOR
JUNIPER UNMANNED, INC   |  INFINITY BIO, INC.
MALEK 
 
FAHEM 
DIRECTOR
INFINITY BIO, INC.
MATTHEW 
 
HELLAUER 
DIRECTOR
INFINITY BIO, INC.
BENJAMIN 
 
LARMAN 
DIRECTOR, EXECUTIVE OFFICER
INFINITY BIO, INC.
H. 
BENJAMIN 
LARMAN 
EXECUTIVE OFFICER, DIRECTOR
INFINITY BIO, INC.
JOY 
 
NASSIF 
EXECUTIVE OFFICER, DIRECTOR
INFINITY BIO, INC.
JOY 
M 
NASSIF 
EXECUTIVE OFFICER, DIRECTOR
INFINITY BIO, INC.
CAROLINE 
 
POPPER 
EXECUTIVE OFFICER, DIRECTOR
CLAROS DIAGNOSTICS INC   |  INNOVATIVE BIOSENSORS INC   |  NANOMR, INC.   |  RAPID PATHOGEN SCREENING INC   |  RPS DIAGNOSTICS, INC.   |  20/20 GENESYSTEMS, INC.   |  BALX HOLDINGS, LLC   |  SIDX, INC.   |  INFINITY BIO, INC.   |  PANGIA BIOTECH, INC.
HERMAN 
 
SCHOLTZ 
DIRECTOR
INFINITY BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-08-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-06-13 
2025-03-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-02-18 
2024-06-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-16 
2023-06-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#